Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50048997
TargetTyrosine-protein phosphatase non-receptor type 2(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Inhibition of full length recombinant N-terminal GST-tagged human TCPTP expressed in Escherichia coli using pNPP as substrate preincubated for 10 min...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CD45 cytoplasmic domain (584 to 1281 residues) expressed in yeast using pNPP as substrate preincubated for 10 mins followed by su...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of recombinant human PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human CD45 cytoplasmic domain (584 to 1281 residues) expressed in yeast using pNPP as substrate preincubated for 10 mins followed by su...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of recombinant human PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of full length recombinant N-terminal GST-tagged human TCPTP expressed in Escherichia coli using pNPP as substrate preincubated for 10 min...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of full length recombinant N-terminal GST-tagged human TCPTP expressed in Escherichia coli using pNPP as substrate preincubated for 10 min...More data for this Ligand-Target Pair
TargetDual specificity protein phosphatase 3(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of human VHR expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after ...More data for this Ligand-Target Pair
TargetDual specificity protein phosphatase 3(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of human VHR expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of recombinant human PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
TargetDual specificity protein phosphatase 3(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 8.50E+3nMAssay Description:Inhibition of human VHR expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after ...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibition of human CD45 cytoplasmic domain (584 to 1281 residues) expressed in yeast using pNPP as substrate preincubated for 10 mins followed by su...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 9.20E+3nMAssay Description:Inhibition of recombinant human PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
TargetDual specificity protein phosphatase 3(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 9.40E+3nMAssay Description:Inhibition of human VHR expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of full length recombinant N-terminal GST-tagged human TCPTP expressed in Escherichia coli using pNPP as substrate preincubated for 10 min...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 9.90E+3nMAssay Description:Inhibition of recombinant human PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
TargetDual specificity protein phosphatase 3(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human VHR expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 2.15E+4nMAssay Description:Inhibition of full length recombinant N-terminal GST-tagged human TCPTP expressed in Escherichia coli using pNPP as substrate preincubated for 10 min...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of human CD45 cytoplasmic domain (584 to 1281 residues) expressed in yeast using pNPP as substrate preincubated for 10 mins followed by su...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Tohoku Medical and Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human CD45 cytoplasmic domain (584 to 1281 residues) expressed in yeast using pNPP as substrate preincubated for 10 mins followed by su...More data for this Ligand-Target Pair
